{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:56:23Z","timestamp":1780606583001,"version":"3.54.1"},"reference-count":32,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T00:00:00Z","timestamp":1371686400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T00:00:00Z","timestamp":1371686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Blood Cancer"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1002\/pbc.24631","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T14:20:54Z","timestamp":1371738054000},"page":"1772-1777","source":"Crossref","is-referenced-by-count":30,"title":["Hearing loss and vestibular dysfunction among children with cancer after receiving aminoglycosides"],"prefix":"10.1002","volume":"60","author":[{"given":"Kenneth S.","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pediatrics; University of Texas Southwestern Medical Center; Dallas Texas"},{"name":"Children's Medical Center; University of Texas Southwestern Medical Center; Dallas Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Bach","sequence":"additional","affiliation":[{"name":"Children's Medical Center; University of Texas Southwestern Medical Center; Dallas Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Shoup","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology; University of Texas Southwestern Medical Center; Dallas Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi J.","family":"Winick","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; University of Texas Southwestern Medical Center; Dallas Texas"},{"name":"Children's Medical Center; University of Texas Southwestern Medical Center; Dallas Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,6,20]]},"reference":[{"key":"10.1002\/pbc.24631-BIB0001|pbc24631-cit-0001","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1002\/pbc.24631-BIB0002|pbc24631-cit-0002","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1182\/blood-2007-10-117150","article-title":"25 year follow-up among survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor study","volume":"111","author":"Mody","year":"2008","journal-title":"Blood"},{"key":"10.1002\/pbc.24631-BIB0003|pbc24631-cit-0003","doi-asserted-by":"crossref","first-page":"e1229","DOI":"10.1542\/peds.2007-0178","article-title":"Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: A report from the Children's Oncology Group","volume":"120","author":"Gurney","year":"2007","journal-title":"Pediatrics"},{"key":"10.1002\/pbc.24631-BIB0004|pbc24631-cit-0004","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/138161207779313731","article-title":"Aminoglycoside-induced ototoxicity","volume":"13","author":"Selimoglu","year":"2007","journal-title":"Curr Pharm Design"},{"key":"10.1002\/pbc.24631-BIB0005|pbc24631-cit-0005","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/MOO.0b013e32833e05ec","article-title":"Cellular mechanisms of aminoglycoside ototoxicity","volume":"18","author":"Warchol","year":"2010","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1002\/pbc.24631-BIB0006|pbc24631-cit-0006","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0014-2999(98)00108-3","article-title":"Polyamine-like actions of aminoglycosides and aminoglycoside derivatives at NMDA receptors","volume":"347","author":"Segal","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/pbc.24631-BIB0007|pbc24631-cit-0007","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00125817-200209000-00004","article-title":"Genetic susceptibility to aminoglycoside ototoxicity: How many are at risk","volume":"4","author":"Tang","year":"2002","journal-title":"Genet Med"},{"key":"10.1002\/pbc.24631-BIB0008|pbc24631-cit-0008","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/01.mlg.0000161355.28073.f5","article-title":"Audiologic testing and molecular analysis of 12S rRNA in patients receiving aminoglycosides","volume":"115","author":"Gurtler","year":"2005","journal-title":"Laryngoscope"},{"key":"10.1002\/pbc.24631-BIB0009|pbc24631-cit-0009","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMc0806396","article-title":"Prevalence of mitochondrial 1555A\u2009\u2192\u2009G mutation in European children","volume":"360","author":"Bitner-Glindzicz","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1002\/pbc.24631-BIB0010|pbc24631-cit-0010","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1056\/NEJMc0806397","article-title":"Prevalence of mitochondrial 1555A\u2009\u2192\u2009G mutation in adults of European descent","volume":"360","author":"Vandebona","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1002\/pbc.24631-BIB0011|pbc24631-cit-0011","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbrc.2005.11.156","article-title":"Extremely low penetrance of deafness associated with the mitochondrial 12S rRNA mutation in 16 Chinese families: Implication for early detection and prevention of deafness","volume":"340","author":"Dai","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/pbc.24631-BIB0012|pbc24631-cit-0012","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/GIM.0b013e318156dd07","article-title":"Pharmacogenomic testing to prevent aminoglycoside-induced hearing loss in cystic fibrosis patients: Potential impact on clinical, patient, and economic outcomes","volume":"9","author":"Veenstra","year":"2007","journal-title":"Genet Med"},{"key":"10.1002\/pbc.24631-BIB0013|pbc24631-cit-0013","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1128\/AAC.45.9.2502-2509.2001","article-title":"Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy","volume":"45","author":"Mulheran","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/pbc.24631-BIB0014|pbc24631-cit-0014","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00006454-199704000-00003","article-title":"Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on antimicrobial treatment of febrile Neutropenia in children","volume":"16","author":"Charnas","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/pbc.24631-BIB0015|pbc24631-cit-0015","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(05)79447-2","article-title":"Ototoxicity induced by once-daily gentamicin","volume":"351","author":"El Bakri","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/pbc.24631-BIB0016|pbc24631-cit-0016","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1542\/peds.114.1.e111","article-title":"Extended-interval aminoglycoside administration for children: A meta-analysis","volume":"114","author":"Contopoulos-Ioannidis","year":"2004","journal-title":"Pediatrics"},{"key":"10.1002\/pbc.24631-BIB0017|pbc24631-cit-0017","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/000348940511400911","article-title":"Changes in vestibular evoked myogenic potentials after Meniere attacks","volume":"114","author":"Kuo","year":"2005","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1002\/pbc.24631-BIB0018|pbc24631-cit-0018","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archotol.127.9.1069","article-title":"Diagnostic value of prolonged latencies in the vestibular evoked myogenic potential","volume":"127","author":"Murofushi","year":"2001","journal-title":"Arch Otolaryngol"},{"key":"10.1002\/pbc.24631-BIB0019|pbc24631-cit-0019","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/MAO.0b013e3181845854","article-title":"Analysis of vestibular testing in patients with vestibular schwannoma based on the nerve of origin, the localization, and the size of the tumor","volume":"29","author":"Suzuki","year":"2008","journal-title":"Otol Neurotol"},{"key":"10.1002\/pbc.24631-BIB0020|pbc24631-cit-0020","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1212\/01.wnl.0000297554.21221.a0","article-title":"Otolith dysfunction in vestibular neuritis: Recovery pattern and a predictor of symptom recovery","volume":"70","author":"Kim","year":"2008","journal-title":"Neurology"},{"key":"10.1002\/pbc.24631-BIB0021|pbc24631-cit-0021","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/00016489950180559","article-title":"Vestibular-evoked myogenic potentials in patients with dehiscence of the superior semicircular canal","volume":"119","author":"Brantberg","year":"1999","journal-title":"Acta Otolaryngol"},{"key":"10.1002\/pbc.24631-BIB0022|pbc24631-cit-0022","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/1352458506070940","article-title":"Vestibular click-evoked myogenic potentials: Sensitivity and factors determining abnormality in patients with multiple sclerosis","volume":"13","author":"Patko","year":"2007","journal-title":"Mult Scler"},{"key":"10.1002\/pbc.24631-BIB0023|pbc24631-cit-0023","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/00005537-200306000-00014","article-title":"Vestibular evoked myogenic potentials in brainstem stroke","volume":"113","author":"Chen","year":"2003","journal-title":"Laryngoscope"},{"key":"10.1002\/pbc.24631-BIB0024|pbc24631-cit-0024","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1055\/s-0042-1745632","article-title":"Vestibular evoked myogenic potentials: Preliminary results","volume":"12","author":"Akin","year":"2001","journal-title":"J Am Acad Audiol"},{"key":"10.1002\/pbc.24631-BIB0025|pbc24631-cit-0025","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3766\/jaaa.14.9.5","article-title":"The effects of click and tone-burst stimulus parameters on the vestibular evoked myogenic potential (VEMP)","volume":"14","author":"Akin","year":"2003","journal-title":"J Am Acad Audiol"},{"key":"10.1002\/pbc.24631-BIB0026|pbc24631-cit-0026","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.heares.2006.11.012","article-title":"Prevention of noise- and drug-induced hearing loss with d-methionine","volume":"226","author":"Campbell","year":"2007","journal-title":"Hear Res"},{"key":"10.1002\/pbc.24631-BIB0027|pbc24631-cit-0027","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMc053428","article-title":"Aspirin to prevent gentamicin-induced hearing loss","volume":"354","author":"Sha","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1002\/pbc.24631-BIB0028|pbc24631-cit-0028","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.ki.5002295","article-title":"Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine","volume":"72","author":"Feldman","year":"2007","journal-title":"Kidney Int"},{"key":"10.1002\/pbc.24631-BIB0029|pbc24631-cit-0029","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/00016480802008199","article-title":"Protective effect of edaravone against tobramycin-induced ototoxicity","volume":"129","author":"Asplund","year":"2009","journal-title":"Acta Otolaryngol"},{"key":"10.1002\/pbc.24631-BIB0030|pbc24631-cit-0030","unstructured":"National Institute on Deafness and Other Communication Disorders (NIDCD) Outcomes research in children with hearing loss: Statistical report: Prevalence of hearing loss 2006. Available from http:\/\/www.nidcd.nih.gov\/funding\/programs\/hb\/outcomes\/report.htm"},{"key":"10.1002\/pbc.24631-BIB0031|pbc24631-cit-0031","unstructured":"American Speech-Language-Hearing Association 1997 Guidelines for Audiologic Screening [Guidelines]. Available from www.asha.org\/policy"},{"key":"10.1002\/pbc.24631-BIB0032|pbc24631-cit-0032","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/01.mao.0000169051.69254.85","article-title":"Vestibular rehabilitation therapy in children","volume":"26","author":"Medeiros","year":"2005","journal-title":"Otol Neurotol"}],"container-title":["Pediatric Blood & Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.24631","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.24631","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/pbc.24631\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T13:41:42Z","timestamp":1688305302000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.24631"}},"subtitle":["Hearing Loss After Receiving Aminoglycosides"],"short-title":[],"issued":{"date-parts":[[2013,6,20]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"URL":"https:\/\/doi.org\/10.1002\/pbc.24631","archive":["Portico"],"relation":{},"ISSN":["1545-5009"],"issn-type":[{"value":"1545-5009","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6,20]]}}}